Founded in 2013, aws Gründerfonds is a venture capital firm based in Vienna, Austria. The firm focuses on investing in start-ups headquartered in Austria.
aws Gründerfonds is Austria's $70 million venture capital fund. As co-investors, the company invests in Austrian high-growth start-ups in their later seed and early stage phase.
aws Gründerfonds' investments include Themis Bioscience, eyeson, Adverity, Secureo GmbH, CheckYeti, Zizoo, ImageBiopsy Lab, ToolSense, Crystalline Mirror Solutions, Storyclash and RateBoard.
They exited their investments in Hitbox Entertainment an sendHybrid.
Themis is developing immune-modulation therapies for infectious diseases and cancer leveraging its versatile technology platform and advanced understanding of immune system mechanisms
Anna Schauppenlehner, MA
Risk Analyst, Controller
Bernhard Ungerbock, MSc
Mag. Nina Dohrau, MBA
Markus Jandrinitsch, MSc
Michael Isima, MSc